☰

Wendy K. Rathmell - Publications

Affiliations: 
Genetics & Molecular Biology University of North Carolina, Chapel Hill, Chapel Hill, NC 
Area:
Genetics, Molecular Biology
Tree Info Grants Similar researchers PubMed Report error

10 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Rojas JD, Papadopoulou V, Czernuszewicz T, Rajamahendiran R, Chytil A, Chiang Y, Chong D, Bautch VL, Rathmell WK, Aylward S, Gessner R, Dayton P. Abstract 1958: Early treatment response detected in a murine clear cell renal cell carcinoma model in response to combination therapy with antiangiogenic and notch inhibition therapy using a non-invasive imaging tool Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-1958  0.382
2018 Yin Q, Hung SC, Rathmell WK, Shen L, Wang L, Lin W, Fielding JR, Khandani AH, Woods ME, Milowsky MI, Brooks SA, Wallen EM, Shen D. Integrative radiomics expression predicts molecular subtypes of primary clear cell renal cell carcinoma. Clinical Radiology. PMID 29801658 DOI: 10.1016/J.Crad.2018.04.009  0.44
2017 Chang EH, Chong WK, Kasoji SK, Fielding JR, Altun E, Mullin LB, Kim JI, Fine JP, Dayton PA, Rathmell WK. Diagnostic accuracy of contrast-enhanced ultrasound for characterization of kidney lesions in patients with and without chronic kidney disease. Bmc Nephrology. 18: 266. PMID 28793871 DOI: 10.1186/S12882-017-0681-8  0.312
2016 Haake SM, Weyandt JD, Rathmell WK. Insights into the Genetic Basis of the Renal Cell Carcinomas from the Cancer Genome Atlas (TCGA). Molecular Cancer Research : McR. PMID 27330105 DOI: 10.1158/1541-7786.MCR-16-0115  0.444
2016 Haake SM, Li J, Bai Y, Kinose F, Fang B, Welsh EA, Zent R, Dhillon J, Pow-Sang JM, Chen YA, Koomen JM, Rathmell WK, Fishman M, Haura EB. Tyrosine Kinase Signaling in Clear Cell and Papillary Renal Cell Carcinoma Revealed by Mass Spectrometry-Based Phosphotyrosine Proteomics. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 27220961 DOI: 10.1158/1078-0432.Ccr-15-1673  0.401
2016 Chism DD, Rathmell WK. Kidney cancer: Rest ASSUREd, much can be learned from adjuvant studies in renal cancer. Nature Reviews. Nephrology. PMID 27108841 DOI: 10.1038/Nrneph.2016.58  0.37
2015 Fahey CC, Rathmell WK. A tale of two cancers: Complete genetic analysis of chromophobe renal cell carcinoma contrasts with clear cell renal cell carcinoma. Molecular & Cellular Oncology. 2: e979686. PMID 27308442 DOI: 10.4161/23723556.2014.979686  0.409
2013 Creighton CJ, Morgan M, Gunaratne PH, Wheeler DA, Gibbs RA, Robertson G, Chu A, Beroukhim R, Cibulskis K, Signoretti S, Vandin F, Wu HT, Raphael BJ, Verhaak RGW, Tamboli P, ... ... Rathmell WK, et al. Comprehensivemolecular characterization of clear cell renal cell carcinoma Nature. 499: 43-49. DOI: 10.1038/Nature12222  0.484
2012 Khandani AH, Cowey CL, Moore DT, Gohil H, Rathmell WK. Primary renal cell carcinoma: relationship between 18F-FDG uptake and response to neoadjuvant sorafenib. Nuclear Medicine Communications. 33: 967-73. PMID 22714005 DOI: 10.1097/MNM.0b013e3283561837  0.425
2009 Wallen EM, Brannon A, Pruthi RS, Reddy A, Seiler M, Ganeson S, Bhanot G, Rathmell W. DISTINCT MOLECULAR SUBTYPES OF CLEAR CELL RENAL CELL CARCINOMA IDENTIFIED BY SIMPLIFIED MRNA PROFILING PREDICTS CLINICAL OUTCOME Journal of Urology. 181: 111-112. DOI: 10.1016/S0022-5347(09)60319-0  0.38
Show low-probability matches.